Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Lymphoma 5Peripheral Nervous System Diseases 4Breast Neoplasms 4Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Head and Neck Neoplasms 3Stomatitis 2Stomach Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Mucositis 2Malnutrition 2Colorectal Neoplasms 2Wilms Tumor 1Sarcopenia 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pain 1Oral Complications 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Plasma Cell 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Extranodal NK-T-Cell 1Lymphangioleiomyomatosis 1Lung Neoplasms 1

Interventions

Surveys and Questionnaires 1Surgical Procedures, Operative 1Radiation 1Induction Chemotherapy 1Immunonutrition Diet 1Heart Rate 1Glutamine 1Gastropexy 1Fundoplication 1Esomeprazole 1Endoscopy, Digestive System 1Drug Therapy 1Dietary Supplements 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Esophagitis × Glutamine × Clear all
NCT01952847 2022-06-15

Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis

M.D. Anderson Cancer Center

Phase 3 Terminated
77 enrolled 28 charts
Other

Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡